StockGlow

Nykode Therapeutics AS (5VB.F)

Nykode Therapeutics AS, a clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases.

0.25-0.00%Healthcare
Compare 5VB.F with
StockGlow Score
80
Bullish
BearishBullish
1 year ago+117.5%

The outlook

Nykode Therapeutics AS currently reads as bullish based on above its 50- & 200-day averages, 60% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range60% of the way from its 52-week low to high
Market cap
$81.5M
52-wk high
0.36
52-wk low
0.09
50-day avg
0.25
200-day avg
0.22
Trailing P/E
—

Similar stocks

OSP2.HMUSU Ventures AG$9.30+1.31%9282.TIchigo Green Infrastructure Investment Corporation$46,750.00-0.21%CPEN.SWCastle Private Equity AG$2.76-3.50%9GJ.FHorisont Energi AS N$0.10-0.21%HFC.FHF Company SA$3.91-0.51%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy